Registration Now Open!
AARM Webinar Series: August 24-28, 2020, 7:00 - 9:00 pm Eastern - online.
Please note that CME credits are not available for watching recordings. NDs may obtain CE credits for watching recordings.
Post-Conference Accredited Courses: Focus on Cardiology, Oncology, Auto immune, and Thyroid.
Free with the on-site 2020 Annual International Restorative Medicine Conference registration, this package of recorded lectures is valued at $450. Each recorded lecture will be aired online as part of the AARM Webinar Series August 24-28 from 7:00 - 9:00pm Eastern. A live Q&A section will follow each lecture. The American Academy of Family Physicians has approved the AARM webinar series 8/24-8/28 for up to 10 CME Prescribed credits. Physicians must watch the webinars at the designated times to earn credits. Conference attendees will receive a link to access the online webinars after the live conference concludes.
Faculty members and topics for the Post-Conference webinars are:
Monday, August 24, 2020: 7:00pm – 9:00pm Eastern:
The Role of Vascular Biology, Nutrition and Nutraceuticals in the Prevention and Treatment of Hypertension and Cardiovascular Disease
Mark Houston, M.D., M.S., MSc, ABAARM, FAARM, FACP, FAHA, FASH, FACN, FAARM, DABC
Dr. Houston is tripled boarded in hypertension as an American Society of Hypertension (ASH) specialist and Fellow of the American Society of Hypertension (FASH), Internal Medicine (ABIM) and Anti-aging medicine (ABAARM). He also has a Masters degree in Human Nutrition from the University of Bridgeport, Connecticut and a Masters of Science degree in Functional and Metabolic Medicine from the University of South Florida in Tampa. The Hypertension Institute was founded in 1995 by Dr. Mark Houston, internist and hypertension and cardiovascular specialist, and Dr. Allen Naftilin, cardiologist and hypertension specialist, at St. Thomas West Hospital and St. Thomas West Hospital in Nashville, TN. The Hypertension Institute immediately received national acclaim as one of the leading Institutes in the US for the treatment of hypertension and related cardiovascular disorders. In 2000, the Hypertension Institute was recognized as one of the top Cardiovascular Centers in the Southeast by the Consortium of Southeastern Hypertension Centers (COSEHC).
- Review the literature for the underlying mechanisms of hypertension, vascular biology.
- Evidence-based review of the efficacy of nutrition, lifestyle factors and nutraceuticals in the prevention and treatment of cardiovascular disease.
- Evidence based review of anti-hypertensive drug – nutrient interactions.
Tuesday, August 25, 2020: 7:00 pm – 9:00pm Eastern
Keto Anyone? Timing for Carbohydrate Restriction, Fat Restriction, or Fasting in the Cancer Clinic
Dawn Lemanne, MD, MPH
Dr. Lemanne is a board certified medical oncologist and a leading integrative oncologist. She holds a faculty appointment at the University of Arizona’s Center for Integrative Medicine, is the author of peer-reviewed articles, textbook chapters, and speaks internationally by invitation. Her medical degree was completed at UCSF and she did her clinical oncology fellowship at Stanford University Hospitals. She is the winner of the 2017 American College of Nutrition, Stanley Wallach Award for Advancement of Human Understanding of Nutrition in Cancer. Her private clinic in Oregon attracts patients from around the globe.
Patients diagnosed with cancer are searching for the “right” diet. Dietary patterns popular among cancer patients at present include the extremely low-carbohydrate ketogenic diet, moderate carbohydrate restriction, “paleo,” low fat, alkaline, and plant-based diets including vegan or raw vegan, and intermittent fasting. Peer-reviewed evidence exists for the efficacy of all of these options, but only under certain circumstances. For example, some animal research on invasive prostate cancer demonstrates that alkalization of drinking water starting in the first few weeks of life prevents development of invasive prostate cancer, whereas this maneuver is less effective if started later in life.
The ketogenic diet, defined as severe carbohydrate restriction leading to measurable blood levels of beta hydroxybutyrate, and fasting may be useful in decreasing the side effects of cancer treatment. Animal studies demonstrate an overall survival benefit in certain cancers, but only when these dietary maneuvers are timed precisely to coincide with treatment. Dr. Lemanne will review the best approaches for dietary interventions, and will clarify the conditions when keto diet or fasting is appropriate, and when it is not.
Goals and Objectives:
- Understand how timing in the course of a cancer’s evolution determines whether a dietary intervention is effective or harmful.
- Gain familiarity with the evidence for using moderate carbohydrate restriction in patients with breast and colon cancer.
- Review the growing body of peer-reviewed literature on the safety and efficacy of the ketogenic diet and fasting in patients with cancer.
- Demonstrate how the metabolic effects of fasting differ from the metabolic effects of caloric restriction, and how to exploit these differences
- Review the evidence-based advantages and limitations of the ketogenic diet in cancer therapy
Wednesday, August 26, 2020 - 7:00 - 9:00 pm Eastern
Autoimmune disorders: Herbal and restorative medicine for the most prevalent autoimmune diseases Rheumatoid arthritis, Sjogren's disease and SLE
Eugene Zampieron, ND
This will be a live lecture. Dr. Zampieron a.k.a ‘Dr.Z’ is a licensed Naturopathic physician and a 1990 graduate of Bastyr University of Natural Health Sciences. He is a medical herbalist (MH) and a Registered and certified Professional Member of the American Herbalist Guild (RH(AHG). Dr Z was on the elite founding presidential advisory board that helped firmly establish the University of Bridgeport College of Naturopathic Medicine (UBCNM) as the first accredited naturopathic medical college on the Eastern seaboard. DrZ is currently the senior-most faculty member at UBCNM. He teaches and has taught many courses including botanical medicine, phyto-pharmacognosy, botanical pharmacy, urology, geriatrics, rheumatology, and the History of Natural Medicine. He sees patients both in a private practice in Woodbury, CT and at the UBridgeport Naturopathic clinic (www.UBclinics.org). He presents at international symposiums and webinars frequently in the field.
Thursday, August 27, 2020: 7:00 - 9:00 pm, Eastern
Mitochondrial Toxins and Evidence-Based Natural Protection
Kevin Spelman, PhD
Dr. Spelman is an adjunct assistant professor at the Massachusetts College of Pharmacy and Health Sciences, an adjunct professor of botanical medicine at the National University of Natural Medicine, and a distinguished lecturer at the Maryland University of Integrative Health. He is an internationally recognized expert on the molecular biology and clinical therapeutics of botanical medicines. A past National Institutes of Health postdoctoral fellow and Marie Curie research fellow in the European Union, Dr. Spelman has published 27 scientific papers and 6 chapters. Since 1989, he has practiced phytotherapy, informed by the Ayurvedic system, western herbalism and modern physiology. Dr. Spelman is currently a consultant specializing in new product development, laboratory and cGMP issues and research initiatives.
Goals and Objectives:
- Review literature regarding toxin overload in contemporary society
- Review the literature that evaluates the clinical efficacy of supporting herbs and foods and assess their validity
- Analyze the metabolic effects of the various nutrients which support or inhibit toxin metabolism, and their impact on phase I and II detoxification.
Friday, August 28, 2020: 7:00 - 9:00pm, Eastern
Lecture 1: Harnessing Evolution During Cancer Therapy (7:00-8:00pm)
Dawn Lemanne, MD, MPH
The conventional treatment paradigm oncologists work under advises using the “maximum tolerated dose,” MTD, applied at specific, non-varying frequencies. This is an attempt to kill as many tumor cells as possible while avoiding (sometimes just barely) killing the patient. However, the drawback is competitive release of treatment resistant cells in virtually every case. MTD predictably engenders emergence of treatment-resistance in tumors, and such treatment has now been shown not to prolong survival, but to accelerate death in patients with “incurable” cancers. This lecture will explore recent mathematical modeling and early clinical research that has successfully challenged that approach. This work has resulted in a new treatment paradigm called “adaptive therapy,” under study at Moffitt Cancer Center at the University of South Florida, Arizona State University, and Cleveland Clinic. In cancer treatment, the adaptive therapy approach uses small doses of several antineoplastic pharmaceuticals with varying mechanisms, applied singly or in combination, and at intervals varying based on tumor burden. Integrated into this approach are evidence-based dietary maneuvers, such as carbohydrate restriction, exercise, hyperbaric oxygen therapy, etc. These may require specific timing in tumor evolution and treatment for optimal benefit. The success of the “adaptive therapy” approach is predicted by mathematical models of cancer treatment employing “game theory.” The success of adaptive therapy over MTD has been corroborated in early clinical trials in patients with advanced metastatic prostate cancer and small cell lung cancer.
Goals and Objectives:
- Discuss the evolutionary reasons behind Peto’s paradox: why some multicellular organisms rarely develop cancer, and why humans are prone to cancer.
- Discuss the limitations of the “maximum tolerated dose” paradigm when used in treatment of most advanced, incurable metastatic cancers of adults, and contrast it with the “adaptive therapy” model based on a review of research.
- Review evidence-based support on why adaptive therapy for advanced, metastatic, incurable cancers of adults may be preferred to the older paradigm of “maximum tolerated dose.”
- Review research on why dietary maneuvers such as carbohydrate restriction (such as the ketogenic diet) or dietary alkalization may be particularly powerful when timed to specific moments in tumor evolution.
- Understand the limits of “adaptive therapy,” and list the oncologic conditions wherein adaptive therapy should be avoided
Lecture 2: Drug Induced Nutrient Depletion and Herb/Drug Interactions (8:00 - 9:00pm)
Eugene Zampieron, ND
The use of herbs with conventional therapies may offer an efficacious intervention with an improved risk-benefit ratio. Adding herbs to a practitioner’s lexicon (or visa versa) requires the understanding of herb-drug interactions. Herbs may cause adverse effects in some individuals, as well as interactions with pharmaceutical drugs which may require a readjustment of prescriptions and/or dose levels of the pharmaceutical drugs. Given that many conventional drugs cause nutrient depletions that can lead to physiologically adverse symptoms, an understanding of this mechanism could provide an invaluable aid for health professionals to improve patient health outcomes. This course will also review possible herbal support for health conditions, along with significant herb/drug interactions, and provide a review of databases and information relating to this topic.
Goals and Objectives:
- To recognize potential drug-induced nutrient depletions (DIND) and be able to counsel and make appropriate nutrient recommendations
- To identify the metabolic consequences of DIND's
- To identify potential herb/drug interactions
- To provide alternative therapeutic options for individuals as a substitution for or addition to conventional therapies